Camillo Ricordi
University of Miami
870 Papers
9K Citations
Camillo Ricordi is an academic researcher from University of Miami. The author has contributed to research in topics: Transplantation & Islet. The author has an hindex of 94, co-authored 845 publications. Previous affiliations of Camillo Ricordi include University of British Columbia & University of Padua.
Chat about Author
Papers
Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells.
Manuel Carreno,Laphalle Fuller,James M. Mathew,Gaetano Ciancio,George W. Burke,Violet Esquenazi,Camillo Ricordi,Andreas G. Tzakis,Joshua Miller +8 more
TL;DR: In vitro findings support the notion that (allogeneic) DBMC infusions can induce a T4 suppressor (regulatory) influence and thereby indirectly affect B-cell function.
5
Engineering human renal epithelial cells for transplantation in regenerative medicine
Vita Manzoli,Vita Manzoli,David C. Colter,Sridevi Dhanaraj,Alessia Fornoni,Camillo Ricordi,Antonello Pileggi,Alice A. Tomei +7 more
TL;DR: It is shown that aggregation in three-dimensional spheroids significantly preserved cell viability, proliferation, and trophic factor secretion and that both wild type and GFP-engineered hRECs could be efficiently encapsulated within conformal hydrogel coatings through the authors' fluid dynamic platform and that this resulted in further improvement of cell viability and troPHic factors secretion.
5
Patent
Improvement of viability and function of pancreatic islets
Ismail H. Al-Abdullah,Camillo Ricordi +1 more
- 13 Nov 2002
5
Effect of Exenatide on Gastric Emptying and Graft Survival in Islet Allograft Recipients
Eduardo Moraes Leao Peixoto,Tatiana Froud,L.S. Gomes,L. Mireles Zavala,Andrea Corrales,Eva Herrada,Camillo Ricordi,Rodolfo Alejandro +7 more
- 01 Nov 2011
TL;DR: Long-term exenatide administration up to 4 years was safe in islet transplant recipients, even in the presence of delayed gastric emptying, and the use of new GLP1 analogs with longer half lives and fewer side effects may help to attain higherGLP1 levels, therefore improving islet function and survival.
5
MSCs for Diabetes
Luca Inverardi,Giacomo Lanzoni,Juan Domínguez-Bendala,Camillo Ricordi +3 more
- 01 Jan 2013
TL;DR: The current state of the art in the emerging field of mesenchymal stromal cells use for autoimmune type 1 diabetes is discussed.
5